Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Third Line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05764941
What this trial is testing

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 100
Post-approval studies (Phase 4)UnknownNCT03725423
What this trial is testing

Apatinib for Advanced Lung Squmamous Carcinoma

Who this might be right for
Lung Squamous Cell Carcinoma
Xuzhou Central Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06775743
What this trial is testing

ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Fudan University 53
Testing effectiveness (Phase 2)Looking for participantsNCT06356584
What this trial is testing

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal CancerImmunotherapyRadiotherapy+2 more
Shandong Cancer Hospital and Institute 62
Large-scale testing (Phase 3)Study completedNCT03148366
What this trial is testing

Comparison of the Levofloxacin Sequential Therapy and Quadruple Therapy in Second Line Treatment for HP

Who this might be right for
Helicobacter
National Taiwan University Hospital 560
Testing effectiveness (Phase 2)UnknownNCT04284202
What this trial is testing

PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC

Who this might be right for
NSCLC Stage IVARID1APD-1
The Affiliated Hospital of Qingdao University 30
Large-scale testing (Phase 3)Looking for participantsNCT06911502
What this trial is testing

Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Who this might be right for
Follicular Lymphoma
Celgene 400
Testing effectiveness (Phase 2)UnknownNCT05257122
What this trial is testing

A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Carcinoma
Fudan University 32
Early research (Phase 1)Study completedNCT02686944
What this trial is testing

Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Mendus 6
Early research (Phase 1)Looking for participantsNCT07409805
What this trial is testing

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Who this might be right for
Colorectal Cancer
West China Hospital 9
Testing effectiveness (Phase 2)Study completedNCT02380443
What this trial is testing

AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Mirror Biologics, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT06643793
What this trial is testing

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

Who this might be right for
Colorectal Neoplasms Malignant
Affiliated Hospital of Nantong University 30
Early research (Phase 1)Study completedNCT01735968
What this trial is testing

A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients

Who this might be right for
3rd Line GIST
Novartis Pharmaceuticals 56
Testing effectiveness (Phase 2)Ended earlyNCT01227018
What this trial is testing

PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
Vanderbilt-Ingram Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT04110093
What this trial is testing

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerImmunotherapy
Shanghai Changzheng Hospital 120
Large-scale testing (Phase 3)Study completedNCT00970138
What this trial is testing

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Carcinoma
Fudan University 141
Testing effectiveness (Phase 2)Study completedNCT02449551
What this trial is testing

Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment

Who this might be right for
Advanced Gastric Adenocarcinoma
Samsung Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT02095119
What this trial is testing

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Uterine Cervical Cancer
National Institute of Cancerología 15
Testing effectiveness (Phase 2)UnknownNCT01749072
What this trial is testing

Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung CancerEffects of Chemotherapy
Peking Union Medical College Hospital 120
Post-approval studies (Phase 4)Looking for participantsNCT04332848
What this trial is testing

Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
National Taiwan University Hospital 360
Next Page